Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Noise can play an important role in the initiation and progression of ischemic heart disease. Researchers from the Department of Cardiology at the University Medical Center Mainz have found that noise exposure...
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
2.
Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
3.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
4.
Researchers explore e-bikes for cancer recovery
5.
Study reveals link between new-onset type 2 diabetes and some obesity-related cancers
1.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
2.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
3.
Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options
4.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
5.
Discovering the Benefits of TNK: A Comprehensive Blog Article
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge